High Court’s Wyeth v. Levine Ruling Returns Pre-Emption Status Quo
This article was originally published in The Tan Sheet
Executive Summary
The Supreme Court's ruling in Wyeth v. Levine dashes pharmaceutical industry hopes for broad protection from state product liability lawsuits, but is not expected to trigger a sea-change in current industry operations